CN120699068A - 大规模生产方法 - Google Patents

大规模生产方法

Info

Publication number
CN120699068A
CN120699068A CN202510684688.8A CN202510684688A CN120699068A CN 120699068 A CN120699068 A CN 120699068A CN 202510684688 A CN202510684688 A CN 202510684688A CN 120699068 A CN120699068 A CN 120699068A
Authority
CN
China
Prior art keywords
formula
compound
organic solvent
base
suitable temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202510684688.8A
Other languages
English (en)
Chinese (zh)
Inventor
L·格拉韦勒
F·塞特贝里
A·蒂勒尔
C·金奈尔特
A·韦茅斯-威尔逊
R·克拉克森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galecto Biotech AB
Original Assignee
Galecto Biotech AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galecto Biotech AB filed Critical Galecto Biotech AB
Publication of CN120699068A publication Critical patent/CN120699068A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CN202510684688.8A 2019-12-16 2020-12-16 大规模生产方法 Pending CN120699068A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP19216405.1A EP3838909A1 (en) 2019-12-16 2019-12-16 Large scale process for the preparation of 5-bromopyridin-3-yl-3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1h-1,2,3-triazol-1-yl]- 1-thio-alpha-d-galactopyranoside
EP19216405.1 2019-12-16
PCT/EP2020/086385 WO2021122719A1 (en) 2019-12-16 2020-12-16 Large scale process for the preparation of 5-bromopyridin-3-yl-3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1h-1,2,3-triazol-1-yl]- 1-thio-alpha-d-galactopyranoside and a crystalline form thereof
CN202080085867.5A CN114929719A (zh) 2019-12-16 2020-12-16 大规模制备5-溴吡啶-3-基-3-脱氧-3-[4-(3,4,5-三氟苯基)-1H-1,2,3-三唑-1-基]-1-硫代-α-D-吡喃半乳糖苷及其结晶形式的方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN202080085867.5A Division CN114929719A (zh) 2019-12-16 2020-12-16 大规模制备5-溴吡啶-3-基-3-脱氧-3-[4-(3,4,5-三氟苯基)-1H-1,2,3-三唑-1-基]-1-硫代-α-D-吡喃半乳糖苷及其结晶形式的方法

Publications (1)

Publication Number Publication Date
CN120699068A true CN120699068A (zh) 2025-09-26

Family

ID=69024098

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202510684688.8A Pending CN120699068A (zh) 2019-12-16 2020-12-16 大规模生产方法
CN202080085867.5A Pending CN114929719A (zh) 2019-12-16 2020-12-16 大规模制备5-溴吡啶-3-基-3-脱氧-3-[4-(3,4,5-三氟苯基)-1H-1,2,3-三唑-1-基]-1-硫代-α-D-吡喃半乳糖苷及其结晶形式的方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202080085867.5A Pending CN114929719A (zh) 2019-12-16 2020-12-16 大规模制备5-溴吡啶-3-基-3-脱氧-3-[4-(3,4,5-三氟苯基)-1H-1,2,3-三唑-1-基]-1-硫代-α-D-吡喃半乳糖苷及其结晶形式的方法

Country Status (7)

Country Link
US (1) US20230063538A1 (cg-RX-API-DMAC7.html)
EP (2) EP3838909A1 (cg-RX-API-DMAC7.html)
JP (2) JP7839730B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220114597A (cg-RX-API-DMAC7.html)
CN (2) CN120699068A (cg-RX-API-DMAC7.html)
CA (1) CA3160971A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021122719A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108558974B (zh) * 2018-04-28 2023-05-23 浙江树人学院 一种糖衍生吡啶三氮唑镍催化剂的制备及应用
WO2025180907A1 (en) 2024-02-26 2025-09-04 Galecto Biotech Ab Specific galactoside inhibitor of galectin-1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2970062C (en) * 2015-01-30 2023-02-28 Galecto Biotech Ab Alpha-d-galactoside inhibitors of galectins
CN109563119A (zh) * 2016-07-12 2019-04-02 格莱克特生物技术公司 半乳糖凝集素的α-D-半乳糖苷抑制剂

Also Published As

Publication number Publication date
EP3838909A1 (en) 2021-06-23
CA3160971A1 (en) 2021-06-24
WO2021122719A1 (en) 2021-06-24
US20230063538A1 (en) 2023-03-02
CN114929719A (zh) 2022-08-19
JP7839730B2 (ja) 2026-04-02
JP2025111532A (ja) 2025-07-30
JP2023506066A (ja) 2023-02-14
EP4077343A1 (en) 2022-10-26
KR20220114597A (ko) 2022-08-17

Similar Documents

Publication Publication Date Title
KR20190039086A (ko) Bet 저해제의 결정질 고체 형태
JP2025111532A (ja) 5-ブロモピリジン-3-イル-3-デオキシ-3-[4-(3,4,5-トリフルオロフェニル)-1h-1,2,3-トリアゾール-1-yl]-1-チオ-アルファ-d-ガラクトピラノシド及びその結晶形を調製するための大規模方法
RU2743098C2 (ru) Новые производные аммония, способ их получения и фармацевтические композиции, содержащие их
CA3016826C (en) Salt of pyridinyl amino pyrimidine derivative, preparation method therefor, and application thereof
CA3142088C (en) Compound used as kinase inhibitor and application thereof
KR20180100211A (ko) 퀴나졸리논 유도체, 이의 제조방법, 약학 조성물 및 적용
JP2022508719A (ja) ガレクチンのガラクトシド阻害剤のプロドラッグ
KR20120084715A (ko) 3α-히드록시, 3β-메틸-5α-프레그난-20-온 (가낙솔론)의 제조 방법
CN101967105A (zh) 具有抗癌活性的β-羟基保护的双癸基季铵盐及制备方法
EP3277683B1 (en) Tricyclic fused derivatives of 1-(cyclo)alkyl pyridin-2-one useful for the treatment of cancer
EP3101020B1 (en) Deuterated quinazolinone compound and pharmaceutical composition comprising same
AU2020410900A1 (en) Compound used as RET kinase inhibitor and application thereof
CN116745286A (zh) 半乳糖凝集素的新型半乳糖苷抑制剂
WO2022189459A2 (en) Novel galactoside inhibitor of galectins
WO2022171561A1 (en) Novel galactoside inhibitor of galectins
WO2025252741A1 (en) Novel galactoside inhibitor of galectins
WO2025252743A1 (en) Novel galactoside inhibitor of galectins

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination